Centro Clinico Colle Cesarano Tivoli Rome Italy Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2010
NCT01246310
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Centre Hospitalier Universitaire de Tivoli

Active Ingredients

Drugs in Phase 4 Trials (1)

myoinositol (1 trial)

Drugs in Other Trials (2)

oxycodone (oxycontin) (1 trial)

sufentanil (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Mental Disorders (Phase 4)

Problem Behavior (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 3